What Are Antitrust Agreements and How Do They Expose Corporations to Liability?

Certain agreements are condemned as per se violations, meaning they are illegal regardless of competitive effect or procompetitive justification. Price-fixing, market allocation, and bid-rigging fall into this category. Other agreements, such as joint ventures, information exchanges, or vertical restraints, are evaluated under the rule of reason, which requires analysis of market power, competitive effect, and any offsetting efficiencies.

The distinction matters enormously for corporate defense strategy. Per se conduct offers no safe harbor and invites criminal prosecution; rule of reason cases allow defendants to present evidence of procompetitive benefits. Courts have expanded rule of reason analysis in recent years, particularly for vertical agreements and nascent collaborations, but horizontal agreements between direct competitors remain highly scrutinized.

Prosecutors and plaintiffs need not prove explicit agreement; circumstantial evidence suffices. Parallel pricing alone does not establish conspiracy, but parallel pricing combined with evidence of meetings, communications, or opportunities to conspire may support liability. Courts examine whether the defendant's conduct was contrary to its independent economic interest, whether the parties had motive and opportunity, and whether the pattern is consistent with collusion rather than independent response to market conditions.

The DOJ has made cartel prosecution a priority, and sentences for individual executives now routinely include prison time. Corporations face fines up to twice the gain to the conspirators or twice the loss to victims, whichever is greater. Individual executives face up to ten years of imprisonment and personal fines. The DOJ's Leniency Program, codified in the Corporate Leniency Policy, offers the first conspirator to report the cartel immunity from criminal prosecution if it meets strict conditions: the corporation must report before the DOJ has evidence of the conspiracy, must cooperate fully, and must cease participation immediately.

Leniency applications are time-sensitive and require careful coordination with counsel to preserve privilege. Many corporations discover cartels through internal audits or whistleblower reports and face a narrow window to evaluate whether leniency is feasible and strategically preferable to defense or settlement.

Private plaintiffs and state attorneys general seek treble damages under Section 4 of the Clayton Act, meaning a corporation found liable for antitrust harm pays three times the actual damages plus attorneys' fees. Class action litigation in this area is common, particularly for consumer-facing price-fixing. Corporations also face injunctive relief requiring cessation of the conduct, modification of business practices, and ongoing monitoring or reporting to the court or agency.

Some agreements that restrict competition in one dimension may be justified by procompetitive effects in another. A joint venture that requires members to share technology or standardize products may restrict price competition but expand output and innovation. Courts evaluate whether the restraint is ancillary to a legitimate collaboration and whether less restrictive alternatives exist. Corporations defending joint ventures or information exchanges must document the procompetitive rationale contemporaneously and avoid using the collaboration as a cover for price-fixing or market allocation.

When the FTC or DOJ investigates, corporations receive civil investigative demands requiring production of documents and testimony. The investigation may proceed in parallel with criminal grand jury activity, creating complex privilege and timing issues. Corporations must carefully manage document preservation, counsel communications, and witness preparation to avoid obstruction liability while protecting legal strategy. In New York federal courts and the Southern District of New York in particular, investigators often focus on the timing and completeness of document production; delayed or selective disclosure can trigger additional obstruction allegations and adverse inferences at trial or in settlement negotiations, even when the underlying antitrust conduct is disputed.